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Abstract
The basic goal of this research is to determine the best combination of light
wavelengths for use as a lighting countermeasure for circadian and sleep disruption
during space exploration, as well as for individuals living on Earth. Action spectra
employing monochromatic light and selected monochromatic wavelength comparisons
have shown that short wavelength visible light in the blue-appearing portion of the
spectrum is most potent for neuroendocrine, circadian, and neurobehavioral regulation.
The studies presented here tested the hypothesis that broad spectrum, polychromatic
fluorescent light enriched in the short wavelength portion of the visible spectrum is more
potent for pineal melatonin suppression in healthy men and women.
subjects were tested across three separate experiments.

A total of 24

Each experiment used a

within-subjects study design that tested eight volunteers to establish the full-range
fluence-response relationship between corneal light irradiance and nocturnal plasma
melatonin suppression. Each experiment tested one of three types of fluorescent lamps
that differed in their relative emission of light in the short wavelength end of the visible
spectrum between 400 and 500 nm. A hazard analysis, based on national and
international eye safety criteria, determined that all light exposures used in this study
were safe. Each fluence-response curve demonstrated that increasing corneal
irradiances of light evoked progressively increasing suppression of nocturnal melatonin.
Comparison

of

these

fluence-response curves

supports the

hypothesis that

polychromatic fluorescent light is more potent for melatonin regulation when enriched in
the short wavelength spectrum.

Introduction
Light is a powerful stimulus for regulating human circadian, neuroendocrine and
neurobehavioral responses [1-3].

Light also has the capacity to restore human health

in clinical applications such as treating winter depression and selected sleep disorders.
In addition, light therapy has been evaluated for healthy individuals who experience
problems associated with intercontinental jet travel, shift work and space flight [1-6].

Neural signals conveying information about environmental light are transmitted from the
retina through the retinohypothalamic tract to the hypothalamic suprachiasmatic nuclei
(SCN) [7]. In turn, the SCN transmit information about lighting and circadian time to the
pineal gland where the hormone melatonin is synthesized [8]. As a result, daily patterns
of light exposure entrain the circadian secretion of melatonin. In most vertebrate species
studied, this pattern results in higher levels of melatonin during the dark, nighttime
hours. In addition, exposure to light of sufficient intensity, wavelength and duration can
acutely suppress high nocturnal melatonin secretion from the pineal gland [9-11]. Once
released into the blood vascular system, melatonin is known to be a pluripotent
hormone that modulates the circadian system at the level of the SCN as well as
numerous peripheral tissues [8,12]. Since melatonin is lipophilic, it readily transfers into
all other body fluids [8]. Recent evidence from sheep has supported the theory that an
important route of the delivery of the melatonin signal to brain tissue is directly from the
pineal gland into the cerebrospinal fluid of the third ventricle [13,14].

In the past 15 years, there have been fundamental advances in the understanding of
photoreceptive input to the circadian and neuroendocrine systems of humans and other
mammals. In 2001, two human analytic action spectra identified 446-477 nm as the
most potent wavelength region for melatonin suppression [10,11]. Those data indicated
that a novel ocular photosensory system, distinct from the visual rods and cones, is
primarily responsible for regulating melatonin in humans. Based on selected
monochromatic wavelength comparisons, further human studies indicated that circadian
phase-shifting, and autonomic stimulation, as well as the acute effects of light on
alertness and vigilance are shifted towards the shorter wavelength, or blue-appearing,
part of the spectrum [15-22].

Seminal discoveries have elucidated the basic anatomy and physiology of the
photosensory system that supplies input to the circadian and neuroendocrine systems.
It is clear that a small population of widely dispersed retinal ganglion cells is directly
responsive to light and projects to the suprachiasmatic nuclei as well as regulatory
nuclei in the central nervous system [23,24]. These intrinsically photosensitive retinal
ganglion cells (ipRGCs) have an expansive arbor of dendrites that form a
"photoreceptive net" for circadian phototransduction [25]. The ipRGCs contain
melanopsin, a vitamin A photopigment that mediates phototransduction in these cells
[26].

Although light detection for circadian, neuroendocrine and neurobehavioral

responses is mediated principally by the ipRGCs, studies on genetically manipulated
rodents [27-30], normal monkeys [31], and humans [15,20,32], clearly demonstrate that
the visual rod and cone photoreceptors also have a role in modulating this physiology.

The goal of the research presented here is to determine the best combination of light
wavelengths for use as a lighting countermeasure for circadian and sleep disruption
during space exploration, as well as for individuals living on Earth. The specific
hypothesis tested in the following studies is that broad spectrum fluorescent light
enriched in the short wavelength portion of the visible spectrum will be more potent for
the regulation of pineal melatonin secretion in healthy men and women.

The data

demonstrate a fluence-response relationship between melatonin suppression and
corneal light irradiances for each of three types of fluorescent light. Comparison of these
fluence-response curves supports the hypothesis that polychromatic fluorescent light is
more potent for melatonin regulation when enriched in the short wavelength spectrum.
Materials and Methods
Hazard Analysis
Since exposure to ultraviolet radiation or intense visible light within the range of 400 nm
to 550 nm can induce damage the eye, an assessment of the three lighting systems
used in this research was necessary [33,34]. An independent hazard analysis based on
guidelines set by the American Conference of Governmental Industrial Hygienists
(ACGIH) and the International Commission on Non-Ionizing Radiation Protection
(ICNIRP) was performed to ensure that subjects were not at risk for photochemical
retinal injury. All measurements of the experimental light panels were taken at 30 cm,
the typical viewing distance of the panels in the study. The primary analysis was
completed using three instruments: 1) a Fieldspec Hand-held Spectroradiometer
manufactured by Analytical Spectral Device (Boulder, CO), Model #FSHH 325-1075, for
all spectroradiometer measurements; 2) a radiometer/photometer (Model 1400BL,
International Light Technologies, Inc., Newburyport, MA) with a silicon-diode detector
head (Model #SEL033), a wide angle output optic (W#11437) and a filter (Y#27475) to
provide photopic illuminance response; and 3) a Minolta Luminance Meter (nt-1), Model
LS-100 (Japan), to measure the panel luminance as a cross-check of the
spectroradiometric radiance measurements at 30-70 cm. Measurements of each panel
also were made with an ultraviolet detector head using an International Light Model
1400 A Radiometer with Model SEL240 (#3682) and Model SEL033 (#3805) detector
(with input Optic W#6874 and Filter UVA #28246) to assure that no hazardous UV
radiation was emitted from the surface of the light panel.

Study design
In each of three studies, eight subjects completed a within-subjects fluence-response
experiment that tested nine light irradiances of polychromatic lamplight and one dark

exposure control night for nocturnal melatonin suppression. The three test lamplights
were standard white light 4,000 K fluorescent, prototype blue-enriched white 17,000 K
fluorescent, and prototype strongly enriched blue (SEB) fluorescent.

Subjects
The healthy females (N=12) and males (N=12) in these studies had a mean ± SEM age
of 24.3 ± 0.4, had a mean wake up time of 07:49h +/- 8 min, and signed an approved
IRB consent document before participating. All subjects demonstrated normal color
vision by both the Ishihara and Farnsworth Munsell D-100 color vision tests (mean ±
SEM score of 83.8 ± 67.2). All subjects were in good ocular and physical health as
assessed by a neurophthalmologist, good mental health as assessed by a clinical
psychologist, and free of signs of substance abuse as determined by urinary
toxicological screens. Ten days prior to entry into the protocol, subjects were confirmed
for sleep-wake stability with routine bedtime starting at midnight (±30 minutes) as
ascertained by actigraphy (Octagonal Sleepwatch, AMI, Ardsley, NY), filling out daily
sleep-wake logs and confirming wake and bed times by calling into a voice mailbox.

Light exposure protocol
Subject pre-experimental adaptation began in the laboratory at 18:00h. During this
period, subjects stayed upright in chairs engaging in reading, studying, or conversation
and were not permitted to sleep. Light levels did not exceed 10 lux at eye level in any
direction of gaze. As described elsewhere, each experiment began at midnight when
subjects were blindfolded and remained awake and sitting upright in darkness for 120
min [10]. While blindfolded, a blood sample was taken just prior to 02:00h and subjects
were then exposed to a 90 min light stimulus from 02:00h to 03:30h. Before
experimental light exposures, blindfolds were removed. Subjects’ pupils were not dilated
in this study. During light exposure, each subject sat quietly with their eyes open and
facing a 119 x 120 cm flat panel of fluorescent lights with their eyes 30 cm from the
central portion of the light-emitting surface. The light was patternless and provided full
retinal field exposure. At 03:30h, a second blood sample was taken. Each subject was

exposed to complete darkness from 02:00h to 03:30h on their control night and was
tested with at least 6 days between each nighttime exposure.

Light production and measurement
Polychromatic light stimuli were produced by equipment donated by Philips Lighting
(Netherlands). Test lamps were white 4,000 K fluorescent lamps (TL5 HO 54W/830),
prototype blue-enriched white 17,000 K fluorescent lamps, and prototype SEB
fluorescent lamps housed in Strato Luminaires (Model TPH 710) containing high-speed
electronic ballasts. Each luminaire was electronically dimmable down to 40 µW/cm2. An
additional neutral density filter panels were used to further adjust the intensity of the
light levels below 40 uW/cm2: 0.3 ND (0.3 optical density; 50% transmittance), 0.6 ND
(0.6 OD; 25% transmittance) and 0.9 ND (0.9 OD; 12.5% transmittance) (Rosco
Laboratories, Stamford, CT). Spectroradiometric and photon flux assessments of the
wavelengths at the level of subjects' corneas were done with a portable
spectroradiometer with a fiber optic sensor (ASD, Boulder, CO, FieldSpec Model #FShh
325-1075P). The spectral power distributions of the lamplights are shown in Figure 1.
Routine measurement of the light irradiance (µW/cm2) was done with International Light
Radiometer/Photometer 1400A (Newport, MA) with an SEL033 #6857 detector head
with an F #23102 filter and cosine correction. All spectroradiometric and radiometric
equipment was calibrated annually with a standard lamp traceable to NIST.

Light

irradiances and illuminances were measured at volunteers' eye level immediately before
and after the 90 min exposure. Additional spot measures were taken with a 1˚
luminance meter (Minolta Camera Co. LTD., Japan, #301749) each half hour of the
exposure to ensure stimulus stability.

For each fluence-response study, intensities

ranged over a four log unit photon flux range of 1010 to 1014 photons/cm2.

Fig. 1. These graphs show the SPD of the polychromatic light sources. The top SPD is from a standard
white fluorescent lamp (4000 K CCT). The middle SPD graph is from a prototype white appearing, blueenriched lamp (17,000 K CCT). The bottom SPD is from aprototype SEB lamp. CCT, correlated color
temperature; SEB, strongly enriched blue; SPD, spectral power distribution.

Melatonin assay
As detailed elsewhere, radioimmunoassy (RIA) was used to assay plasma for melatonin
[10,35]. Duplicate 200 l aliquots of each unknown and control sample were extracted
into chloroform. Then chloroform was removed by centrifugation, samples were
resuspended in assay buffer, washed twice with petroleum ether and evaporated to
dryness. Samples then were resuspended with deionized water, incubated for 48 hr with

radiolabeld ligand and R1055 antiserum, precipitated by centrifugation and radioactivity
was quantified [10,35]. This RIA had a minimum detection limit of 0.5 - 2.0 pg/mL.

Calculation of effective rod, cone and melanopsin photoreceptor illuminances
To calculate human rod, cone and melanopsin photoreceptor illuminances, the lamp
SPDs

entered into a toolbox worksheet that is a software model for human

photoreception freely available online [36]. The SPDs for the experiments shown here
were imported into the worksheet in 1 nm increments between 378 and 782 nm. Per
toolbox instructions, all raw negative SPD values were changed to zero.

Statistics
Two-tailed, Students' t-tests were used to assess significance of raw melatonin change
from 02:00h to 03:30h.

Raw melatonin data were then converted to % melatonin

change scores and % control-adjusted change scores as described elsewhere [10].
Sets of pre-exposure melatonin values and % control-adjusted melatonin change scores
were analyzed with one-way, repeated measures ANOVA.

Significant differences

between groups were assessed with post-hoc Fisher PLSD test with alpha of 0.05. The
fluence-response curve for light exposures were calculated and fit using Origin 8.0
(OriginLab Corp., Northhampton, MA).

The curves were fit to an unconstrained

parametric model with the melatonin response (Y) to the corneal irradiance (X) is
predicted by: a theoretical initial Y-response for the curve (A1); the theoretical final Yresponse (“infinite” dose) for the curve (A2); the dose producing a response halfway
between A1 and A2 (X50); and the slope estimator for the curve between A 1 and A2 (p).
These compose the equation:

Y=

A1 - A2

1+ ( X X50 )

p

+ A2

The curve was tested for fit of the data by coefficient of correlation (R2).

Results
Based on national and international safety criteria, the hazard analysis determined that
all intended study exposures used in this study were safe [33,34].

The radiance

measurements did not exceed the long-term limit of 10 mW/(cm2·sr). Spectral weighting
of the 4,000 K, 17,000 K and SEB

spectral power distributions with the blue-light

hazard or B(λ) function provided a maximum effective blue-light radiance value of
0.0094, 0,061, and 0.41, mW/(cm2·sr), respectively. Thus, the SEB panel, the most
blue-enriched of the three fluorescent panels, was less than 5% of the ACGIH and
ICNIRP limits [33,34].

Selected light stimuli characteristics (corneal irradiances, photon fluxes and
illuminances) are provided in Table 1 along with measured mean pupil sizes and
calculated mean retinal irradiances.

Table 1. Selected target corneal irradiances, measured corneal illuminances, corneal photons (380760nm), measured pupil sizes and calculated retinal irradiances of light stimuli.

Fluorescent
Stimulus

Corneal
Irradiance
(µW/cm2)

Corneal
Illuminance
(lux)

Photon Flux
(photons/cm2/s)

Mean
Pupil
Diameter
(mm)

Calculated Retinal
Irradiance
(µW/cm2)

4,000 K

734

2,874

2.03 x 1015

2.72

4.24

4,000 K

40

135

1.14 x 1014

4.19

0.54

4,000 K

11

23

2.64 x 1013

4.72

0.19

17,000 K

800

2,511

1.84 x 1015

3.02

5.90

17,000 K

25

71

4.45 x 1013

4.33

0.37

17,000 K

10

27

1.78 x 1013

4.83

0.18

Strong Blue

1500

2,397

3.28 x 1015

2.28

6.38

Strong Blue

58

91

6.71 x 1014

3.39

0.52

Strong Blue

10

13

1.16 x 1013

4.74

0.18

ANOVA demonstrated a significant effect of light on pupil diameter for the 4,000 K
exposures (F=118.3, df=8, p<0.0001), the 17,000 K exposures (F=102.4, df=8,
p<0.0001), and the SEB exposures (F=104.0, df=8, p<0.0001). The Fisher PLSD test
showed that pupil diameters were significantly larger when exposed to the lowest (1
through 18 μW/cm2) versus higher (40 through 734 μW/cm2) 4,000 K irradiances. For
the 17,000 K exposures, pupil diameters were significantly larger with the lowest (1, 5,
and 10 μW/cm2) versus higher irradiances (20 through 800 μW/cm 2). Finally, for the
SEB exposures, pupil diameters were significantly larger with the lowest (0.8 and 4
μW/cm2) versus higher irradiances (6 through 1500 μW/cm2).

The top graph in Figure 2 compares mean (+ SEM) pre- and post-plasma melatonin
values for each study night from the 4,000 K light exposures. All irradiances at or above
1 µW/cm2 significantly suppressed melatonin (p<0.05 to p<0.005).

Percent control-

adjusted melatonin change scores presented in the bottom graph of Figure 2 showed a
significant effect of light irradiance on melatonin suppression (F=13.24, df=8, p<0.0001).
Increasing irradiances of 4,000 K light exposure evoked progressively larger melatonin
suppressions. The Fisher PLSD test showed that higher irradiances of 4,000 K light
(734 and 274 μW/cm2) elicited significantly stronger melatonin suppression than
irradiances at or below 80 μW/cm2. The 80 μW/cm2 irradiance of 4,000 K light elicited a
significantly stronger melatonin suppression than lower irradiances (8.34, 3.81, and 1
μW/cm2), while 39.5 and 18 μW/cm2 elicited significantly stronger melatonin
suppression than the lowest irradiance of 0.8 μW/cm2.

Fig. 2. The top graph compares the mean (+ S.E.M.) pre- and postplasma melatonin values for the 4000
K light exposures. Percent control-adjusted melatonin change scores from these data are presented in
the bottom graph.

For the 17,000 K light exposures, comparison of the mean pre- and post-plasma
melatonin values shows that all corneal irradiances at or above 15 µW/cm 2 significantly
suppressed melatonin (p<0.05 to p<0.005). For the 17,000 K light exposures, percent
control-adjusted melatonin change score showed that there was a significant effect of
light irradiance on melatonin suppression (F=12.48, df=8, p<0.0001). Increasing
irradiances of 17,000 K light evoked progressively larger melatonin suppressions.
Fisher PLSD tests showed that the 800 μW/cm 2 corneal irradiance elicited significantly
stronger melatonin suppression than irradiances at or below 50 μW/cm 2, while the 300
μW/cm2 irradiance produced a significantly stronger melatonin suppression than
irradiances at or below 15 μW/cm2. The intermediate 17,000 K light irradiances of 50
and 25 μW/cm2 evoked significantly stronger melatonin suppressions than irradiances at
or below 25 μW/cm2, and irradiances at or below 10 μW/cm 2, respectively. Lastly, 20
μW/cm2 elicited a stronger melatonin suppression than 10 and 1 μW/cm 2; while 15 and
5 μW/cm2 produced significantly stronger suppressions than 1 μW/cm2.

Comparison of the mean pre- and post-plasma melatonin values of the SEB light
exposures shows that all irradiances at or above 17.4 µW/cm 2 significantly suppressed
melatonin (p<0.05 to p<0.005). For the SEB percent control-adjusted melatonin change
scores, there was a significant effect of light irradiance on melatonin suppression
(F=9.43, df=9, p<0.0001). Increasing irradiances of SEB light exposure evoked
progressively larger melatonin suppressions. Fisher PLSD tests showed that the higher
irradiances of SEB light (1500 and 323 μW/cm 2) elicited significantly stronger melatonin
suppression than irradiances at or below 22 μW/cm 2.

The corneal irradiance 58.4

μW/cm2 elicited significantly stronger melatonin suppression than lower irradiances at or
below 10 μW/cm2, while 22 μW/cm2 elicited significantly stronger melatonin suppression
than irradiances at or below 6 μW/cm2.

Finally, 17.4 μW/cm2 elicited significantly

stronger melatonin suppression than irradiances of 6 and 4 μW/cm2.

Figure 3 shows the mean (+/- SEM) percent change control-adjusted melatonin data
from the three studies presented above were plotted on a log scale of corneal irradiance
along with the best-fit, sigmoidal curve. No mathematical constraints were placed on

this family of curves. The coefficients of correlation for the 4,000 K, 17,000 K, and SEB
curves were 0.96, 0.85 and 0.95, respectively.

Fig. 3. Each fluence–response curve represents data collected from separate cohorts of eight healthy
subjects after exposure to different types of polychromatic fluorescent light. The curve fit parameters and
coefficient of correlation (R2) are included in the upper left portion of each graph.

The curves illustrated in Figure 3 show that there is a progressive steepening of the
slopes (p value) of the curves with greater enrichment with blue light. Further, the
pseudo-linear portions of both the 17,000 K, and SEB curves are shifted to the left in
comparison to the 4,000 K curve. That shift is quantified by comparison of the curve’s
X50 parameters (4,000 K = 95.81, 17,000 K = 16.40, and SEB = 21.00).

Hence,

approximately six times as much light is needed to evoke a half-saturation response
from the 4,000 K light versus the 17,000 K light. Similarly, approximately five times as
much light is needed to evoke a half-saturation response from the 4,000 K light versus
the SEB light.

The fluence-response curves in Figure 3 were not mathematically constrained.

In

action spectroscopy, it is not unusual to constrain one or more of the elements (A 1, A2,
p) of the parametric model described above. Including the unconstrained curve fits in
Figure 3, seven different parametric models for curve fitting the melatonin data were
tested. For example, one constrained model that was tested set A 1 = 0. The logic of
that constraint is that darkness (a corneal irradiance of 0) would elicit 0% melatonin
suppression.

The curve fits of all models all had relatively high coefficients of

correlation (r2 ranged from 0.80 to 0.97).

The resulting X50 parameters resulting from

application of the different models also varied in their ranges (4,000 K = 65.8 to 95.81,
17,000 K = 9.57 to 25.40, and SEB = 17.80 to 22.70).

In every case, when a single

parametric model was applied across all sets of fluence-response data, the blueenriched 17,000 K and SEB light elicited smaller half-saturation responses compared to
the 4,000 K light. Across these different parametric models, a range of approximately
three to seven times as much irradiance is needed to evoke a half-saturation response
from the 4,000 K light versus the 17,000 K light.

Similarly, approximately three to five

times as much light is needed to evoke a half-saturation response from the 4,000 K
lamp versus the SEB light.

The effective rod, cone and melanopsin photoreceptor irradiances and the total
irradiances and photopic illuminances were calculated as described above [36]. The

values in Table 2 were derived from the SPDs shown in Figure 1 with photon fluxes of
9.18 or 9.19 x 1014 photons/cm2/sec.

Table 2. Calculated irradiances, photopic illuminances v(λ),, and human photopigment illuminances
relative to three broad spectrum lights (32).
Retinal Photopigment Weighted
Illuminances
(α-opic lux)

Radiometric and Photometric Values
(380 -780 nm inclusive)
Photon Flux
(photons/cm²/s)

Irradiance
(µW/cm2)

Photopic
Illuminance
(lux)

S
Cone

Melanopsin
ipRGC

Rod

M
Cone

L
Cone

4,000 K
Light

9.18E+14

329

1,141

688

711

833

1,011

1,107

17,000
K Light

9.19E+14

357

884

1,713

1,212

1,119

982

889

SEB
Light

9.18E+14

379

581

2,682

1,613

1,298

872

647

Discussion
This study tested three types of broad spectrum fluorescent lamps that differed in their
relative emission of light in the short wavelength end of the visible spectrum between
400 and 500 nm. A hazard analysis based on national and international eye safety
criteria, determined that all light exposures used in this study were safe [33,34]. The
melatonin data comprise three full fluence-response relationships between graded
exposures from the different types of fluorescent light and melatonin suppression in
healthy humans. Comparison of the three fluence-response curves support the
hypothesis that polychromatic fluorescent light is more potent for melatonin regulation
when enriched in the short wavelength portion of the visible spectrum.

Action spectroscopy is a powerful tool for revealing the underlying physiology of
phototransduction. The development of fluence-response curves using monochromatic
light (<15 nm half-peak bandwidths) is fundamental for creating action spectra [37-39].
That approach has been used extensively for clarifying the sensitivity of neuroendocrine
and circadian responses to light [20,23,31,39,40]. Similar to the fluence-response
curves developed with monochromatic light for melatonin suppression in humans, the
polychromatic fluence-reponse curves presented here have strong fits to four parameter
parabolic curves [10,11]. There is, however, a major methodological difference between
the experiments reported here versus the earlier human melatonin action spectra.
Specifically, the volunteers’ eyes were not pharmacologically dilated in the current
studies.

As shown in Table 1, the mean pupillary size varied across different

irradiances and lamp types. Pupil size, in part, modifies retinal irradiance. Lighting
countermeasures for circadian and sleep disruption during space exploration, as well as
for individuals living on Earth, will be used when individuals have freely reactive pupils.

It is useful to compare the results reported here to two other full-range human melatonin
suppression fluence-response curves in subjects with freely-reactive pupils [41,42]. In
one study, the light stimuli were produced by narrow bandwidth blue solid-state light
emitting diodes (LEDs, 469 nm peak, 26 nm half-peak bandwidth) with an exposure
system identical to the one described here [41].

The calculated irradiance for a half-

saturation response (X50) from the blue LEDs was 14 µW/cm2 - similar to the X50s of 16
and 21 µW/cm2 for the 17,000 K and SEB fluorescent lamps, respectively. In contrast,
the 4,000 K lamps had a much higher X50 of 96 µW/cm2. Together, these results
indicate that blue-enriched polychromatic light elicits stronger melatonin suppression
compared to equivalent intensities of light with lower emissions in the blue-appearing
portion of the visible spectrum. Importantly, the data indicate that there may be limits to
blue-enriching a light source for evoking stronger melatonin regulation; the halfsaturation responses from the SEB and 17,000 K exposures are roughly similar even
though the SEB lamps emitted higher concentrations of energy in the blue portion of the
spectrum compared to the 17,000 K lamps.

Another study reported fluence-response curves for both phase-shifting the melatonin
rhythm and suppressing nocturnal melatonin relative to cool white fluorescent light
exposures [42]. The study conditions and light exposure techniques were very different
from the fluence-response results discussed above.

Notably, light exposures were

significantly longer (390 min versus 90 min). Further, subjects were adapted to an
ambient illuminance of <10 lux for 50 hours, had an 8 hour sleep opportunity in
darkness, and then a 5 hour period in <10 lux before the experimental light exposures.
The resultant melatonin phase-shift and suppression fluence-response curves yielded
X50 values of 36 and 32 µW/cm2, respectively. It is likely the exposure duration and
lengthy dim light/darkness adaptation contributed greatly to the differences between the
X50 value of 96 µW/cm2 relative to the 4,000 K data reported here. It has been shown
that increasing light exposure duration from 30 to 120 min increases the melatonin
suppression in human subjects [43]. Similarly, prior dim light exposure has been shown
to increase the sensitivity to light in melanopsin ganglion cells in rats as well as for
melatonin suppression in humans [32,44-46].

A variety of behavioral and physiological changes relative to correlated color
temperature (CCT) of broad spectrum fluorescent lights have been measured [47, for
review]. Generally, higher color temperature lamps emit more energy in the blue part of
the visible spectrum than lower color temperature lamps [48]. Lamps with higher CCT
were found to evoke a stronger melatonin suppression compared to lamps with lower
CCT in healthy humans [49-51]. Additionally, compared to low CCT light, higher CCT
light was observed to have a more potent effect on reducing the nocturnal fall of core
temperature, decreasing body temperature change to cold challenge, and increasing
the morning rise in core temperature [50,52,53]. Furthermore, EEG frequency has been
shown to increase under high CCT as compared to lower CCT illumination [54]. Finally,
a study on the effects of illumination prior to sleep showed that deep sleep was reduced
under high CCT compared to low CCT during the first half of sleep [55]. This composite
literature consistently demonstrates that higher CCT light induces stronger acute
neuroendocrine and neurobehavioral effects than lower CCT light in healthy subjects.
Those findings are generally consistent with the analytical action spectra that

demonstrate the blue-appearing portion of the visible spectrum is more potent for
circadian, neuroendocrine and neurobehavioral regulation.

Only three studies have compared cool white fluorescent light versus blue-enriched
fluorescent light (17,000 K) for phase-shifting the circadian system in humans. Two
studies compared equal photon fluxes of 4,100 K versus 17,000 K light for phasedelaying or phase-advancing dim light melatonin onset (DLMO) [56,57].

Both studies

showed that each type of light elicited strong DLMO phase-shifts with no significant
difference between groups. Those studies used relatively high, potentially saturating,
light levels that are commonly used for evoking phase-shifts (4.2 x 1015
photons/cm2/sec, or 5,000 – 4,000 lux). A third study compared equal photon doses of
lower light levels (1 x 1014 photons/cm2/s or 134 – 129 lux) of 4,000 K versus 17,000 K
light for eliciting a DLMO phase-delay in healthy subjects [58]. Although the 17,000 K
light caused a greater mean phase-delay shift of 2.1 hours compared to 4,000 K light
that elicited a 1.7 delay, the difference was not statistically significant. These studies
indicate that blue-enriched fluorescent light has greater potency for eliciting acute
biological and behavioral responses but longer term effects like circadian phase-shifting
does not reflect that same sensitivity. Further research is needed to clarify such
differences between short and long term effects of polychromatic light.

Measured radiometric and photometric values for the studies’ lighting stimuli are
provided in Figure 1 and Table 1. Currently, there is not a standardized, single
measurement unit available for quantifying light that regulates the circadian,
neuroendocrine and neurobehavioral effects of light. A recent consensus position was
developed across many of the laboratories that have studied wavelength regulation of
the biological and behavioral effects of light in humans and other species for best
practices for measuring and reporting light stimuli [36]. With that consensus, a freely
available web-based toolbox was provided that permits calculation of the effective
irradiance for each of the human ipRGC, cone and rod photoreceptors that are capable
of driving physiological effects [36]. Table 2 provides the computed effective
photoreceptor illuminances of the three polychromatic lights used in this study. Such

data are intended for making comparisons of polychromatic lights of different spectral
quality significantly more traceable [36].

Examining the calculated photoreceptor illuminances, it is clear that lamplight that is
progressively enriched with short wavelengths is predicted to have increasingly higher S
cone, melanopsin ipRGC, and rod weighted illuminances.

Conversely, those same

lamplights have progressively lower M cone and L cone weighted illuminances. Given
that the ED50 for melatonin suppression of both 17,000 K and SEB lamplight were five
times smaller than that of the 4,000 K lamplight, the empirical melatonin suppression
data support the hypothesis that polychromatic light with increased emissions of short
wavelengths has increased potency for acute regulation of the pineal gland.

The

melatonin data, however, suggest that there are limits to increasing potency of light with
short wavelengths as the SEB light did not have an ED50 lower than the 17,000 K light.

Although it would be desirable to use a single unit for quantifying light that elicits
circadian, neuroendocrine, and neurobehavioral responses ,this is not currently feasible.
Abundant evidence shows that the melanopsin ipRGCs are anatomically and
functionally interconnected with the rods and cones that support vision [20,2732,36,40,59,60]. Light-induced physiological responses reflect input from all of the
retinal photoreceptor classes, with the relative importance of each being highly labile
within and between response types. Consequently, the spectral sensitivity of this
photoreceptive

system

is

fundamentally

context-dependent

[15,17,20,29-

32,36,40,59,60].

The lack of a consistent and adequate method of quantifying light makes it challenging
to replicate experimental conditions or to compare across studies. For this nascent field
of research to mature, different groups of investigators need to use commonly accepted
metrics for reporting spectral response functions to be able to pool results such as those
shown in Table 2. As published data using this measurement system accumulate, it will
then be possible to generate testable hypotheses that predict the spectral
characteristics for a targeted physiological or behavioral response to light.

There are limitations to the data presented here. First, each study employed young
adults. Results from studies with older adults would differ significantly due to agerelated differences such as ocular media transmission [61,62]. Second, although each
fluence-response curve was developed with a complete within-subjects study design,
three separate cohorts of subjects were studied. An ideal comparison of the potency
across three lamplights would have employed the same subjects for all three curves.
That is logistically challenging, however, due to subject compliance and drop out. No
published human neuroendocrine studies yet have provided three full-range fluenceresponse curves within a single subject cohort. Finally, the light exposure technique
involved constant 90 min full retinal field exposures. Such exposures are optimum for
comparing the potency of the three types of lamplight. When used in daily applications
such as the home, workplace or spaceflight environments, exposure conditions rarely
would be full retinal field or continuous. Studies in a variety of architecturally illuminated
spaces are needed to define the optimum illuminances and irradiances that support
vision as well as the biological and behavioral efficacy of built-in lighting.

Risks for the health and safety of astronauts and ground control workers include
disturbed circadian rhythms and sleep loss. Such problems may cause impaired
alertness, loss of concentration, and diminished performance [5,6,63,64]. The broader
research goal was to determine the best combination of wavelengths for a lighting
countermeasure for circadian and sleep disruption during space exploration, and
individuals on Earth. The data presented here provide a first step towards that aim.
NASA has used high illuminances of white fluorescent light as a pre-launch
countermeasure for circadian disruption in astronauts [5]. Solid-state lighting now
provides the potential to provide astronauts light therapy during spaceflight. The retrofit
of the International Space Station (ISS) fluorescent lighting system to solid-state lighting
is scheduled to begin in 2016 [65]. A recent study on the Mars Phoenix Lander ground
crew demonstrated that a blend of countermeasures including exposure to blue solidstate light effectively improved alertness and circadian entrainment [6]. Initial tests of
have probed the ISS lighting system’s capacity for supporting astronaut vision and

regulating melatonin [66]. Lighting countermeasures are promising for general domestic
use in architectural applications or clinically, such as treating specific circadian
disorders. Results from two field studies testing 17,000 K fluorescent lamps in the work
places indicate that this lamplight improved employee alertness and well being [67,68].
Now the door is open to future lighting designs of building interiors that address the
traditional lighting values along with fostering benefits to human health and well being.
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Figure Legends

1. These graphs show the spectral power distribution (SPD) of the polychromatic light
sources. The top SPD is from a standard white fluorescent lamp (4,000 K CCT). The
middle SPD graph is from a prototype white-appearing, blue-enriched lamp (17,000 K
CCT). The bottom SPD is from a prototype strongly enriched blue (SEB) lamp.

2. The top graph compares the mean (+ SEM) pre- and post-plasma melatonin values
for the 4,000 K light exposures. Percent control-adjusted melatonin change scores from
these data are presented in the bottom graph.

3. Each fluence-reponse curve represents data collected from separate cohorts of 8
healthy subjects after exposure to different types of polychromatic fluorescent light. The
curve fit parameters and coefficient of correlation (R2) are included in the upper left
portion of each graph.

